Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T McGuire

Showing results (271-280 of 288) with videos related to

Pageof 29
Sort By:
Cell|June 20, 2015
Immunization for HIV-1 Broadly Neutralizing Antibodies in Human Ig Knockin MicePia Dosenovic, Lotta von Boehmer, Amelia Escolano, et al.
Immunity|December 16, 2018
Inference of the HIV-1 VRC01 Antibody Lineage Unmutated Common Ancestor Reveals Alternative Pathways to Overcome a Key Glycan BarrierMattia Bonsignori, Eric Scott, Kevin Wiehe, et al.
Cell Reports|December 7, 2024
Protein nanoparticle vaccines induce potent neutralizing antibody responses against MERS-CoVCara W Chao, Kaitlin R Sprouse, Marcos C Miranda, et al.
Science (New York, N.Y.)|April 2, 2021
Designed proteins assemble antibodies into modular nanocagesRobby Divine, Ha V Dang, George Ueda, et al.
Biorxiv : the Preprint Server for Biology|December 10, 2020
Designed proteins assemble antibodies into modular nanocagesRobby Divine, Ha V Dang, George Ueda, et al.
Nature|June 18, 2025
R9AP is a common receptor for EBV infection in epithelial cells and B cellsYan Li, Hua Zhang, Cong Sun, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2021
Live Imaging of SARS-CoV-2 Infection in Mice Reveals Neutralizing Antibodies Require Fc Function for Optimal EfficacyIrfan Ullah, Jérémie Prévost, Mark S Ladinsky, et al.
Immunity|August 28, 2021
Live imaging of SARS-CoV-2 infection in mice reveals that neutralizing antibodies require Fc function for optimal efficacyIrfan Ullah, Jérémie Prévost, Mark S Ladinsky, et al.
Cell Reports|July 8, 2021
Isolation and characterization of cross-neutralizing coronavirus antibodies from COVID-19+ subjectsMadeleine F Jennewein, Anna J MacCamy, Nicholas R Akins, et al.
Cell Host & Microbe|June 16, 2021
A single dose of the SARS-CoV-2 vaccine BNT162b2 elicits Fc-mediated antibody effector functions and T cell responsesAlexandra Tauzin, Manon Nayrac, Mehdi Benlarbi, et al.
Pageof 29

Showing results (271-280 of 288) with videos related to

Sort By:
Pageof 29
Cell|June 20, 2015
Immunization for HIV-1 Broadly Neutralizing Antibodies in Human Ig Knockin MicePia Dosenovic, Lotta von Boehmer, Amelia Escolano, et al.
Immunity|December 16, 2018
Inference of the HIV-1 VRC01 Antibody Lineage Unmutated Common Ancestor Reveals Alternative Pathways to Overcome a Key Glycan BarrierMattia Bonsignori, Eric Scott, Kevin Wiehe, et al.
Cell Reports|December 7, 2024
Protein nanoparticle vaccines induce potent neutralizing antibody responses against MERS-CoVCara W Chao, Kaitlin R Sprouse, Marcos C Miranda, et al.
Science (New York, N.Y.)|April 2, 2021
Designed proteins assemble antibodies into modular nanocagesRobby Divine, Ha V Dang, George Ueda, et al.
Biorxiv : the Preprint Server for Biology|December 10, 2020
Designed proteins assemble antibodies into modular nanocagesRobby Divine, Ha V Dang, George Ueda, et al.
Nature|June 18, 2025
R9AP is a common receptor for EBV infection in epithelial cells and B cellsYan Li, Hua Zhang, Cong Sun, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2021
Live Imaging of SARS-CoV-2 Infection in Mice Reveals Neutralizing Antibodies Require Fc Function for Optimal EfficacyIrfan Ullah, Jérémie Prévost, Mark S Ladinsky, et al.
Immunity|August 28, 2021
Live imaging of SARS-CoV-2 infection in mice reveals that neutralizing antibodies require Fc function for optimal efficacyIrfan Ullah, Jérémie Prévost, Mark S Ladinsky, et al.
Cell Reports|July 8, 2021
Isolation and characterization of cross-neutralizing coronavirus antibodies from COVID-19+ subjectsMadeleine F Jennewein, Anna J MacCamy, Nicholas R Akins, et al.
Cell Host & Microbe|June 16, 2021
A single dose of the SARS-CoV-2 vaccine BNT162b2 elicits Fc-mediated antibody effector functions and T cell responsesAlexandra Tauzin, Manon Nayrac, Mehdi Benlarbi, et al.
Pageof 29